NasdaqCM - Nasdaq Real Time Price USD

OncoCyte Corporation (OCX)

2.4600 +0.0050 (+0.20%)
At close: April 24 at 4:00 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
74,892.0000
100,091.0000
159,563.0000
55,419.0000
Total Liabilities Net Minority Interest
54,424.0000
65,799.0000
94,346.0000
21,936.0000
Total Equity Gross Minority Interest
20,468.0000
34,292.0000
65,217.0000
33,483.0000
Total Capitalization
20,468.0000
34,292.0000
65,217.0000
34,991.0000
Common Stock Equity
20,468.0000
34,292.0000
65,217.0000
33,483.0000
Capital Lease Obligations
2,869.0000
3,544.0000
4,364.0000
4,734.0000
Net Tangible Assets
-36,127.0000
-27,341.0000
-15,188.0000
9,287.0000
Working Capital
3,504.0000
13,430.0000
25,023.0000
230.0000
Invested Capital
20,468.0000
34,292.0000
66,530.0000
37,381.0000
Tangible Book Value
-36,127.0000
-27,341.0000
-15,188.0000
9,287.0000
Total Debt
2,869.0000
3,544.0000
5,677.0000
8,632.0000
Share Issued
8,260.7620
5,932.2000
4,611.5950
3,455.8500
Ordinary Shares Number
8,260.7620
5,932.2000
4,611.5950
3,455.8500
12/31/2020 - 12/30/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers